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Copper, a transition metal with essential cellular functions, exerts neurotoxic effects when present in excess by promoting
production of reactive oxygen species (ROS). The aim of the present study was to investigate potential benefits of flavonoid
quercetin against copper-induced toxicity. Results obtained with MTT assay indicate that the effects of quercetin are determined
by the severity of the toxic insult. In moderately injured P19 neuronal cells, concomitant treatment with 150 μM quercetin
improved viability by preventing ROS formation, caspase-3 activation, and chromatin condensation. Western blot analysis
revealed that quercetin reduced copper-induced increase in p53 upregulated modulator of apoptosis (PUMA) expression and
promoted upregulation of nucleoside diphosphate kinase NME1. Levels of p53 and Bax proteins were not affected by both
copper and quercetin. UO126 and wortmannin, inhibitors of ERK1/2 and PI3K/Akt signalling pathways, respectively, prevented
neuroprotective effects of quercetin. In severely injured neurons, 30μM quercetin exerted strong prooxidative action and
exacerbated cytotoxic effects of copper, whereas 150μM quercetin failed to affect neuronal survival. These results demonstrate
the dual nature of quercetin action in copper-related neurodegeneration. Hence, they are relevant in the context of considering
quercetin as a possible therapeutic for neuroprotection and imply that detailed pharmacological and toxicological studies must
be carried out for natural compounds capable of acting both as antioxidants and prooxidants.
1. Introduction
Neurodegenerative diseases, such as Alzheimer’s disease and
Parkinson’ disease, are chronic and progressive disorders
characterized by slow degeneration of neurons and ulti-
mately cell death. Structural changes disable proper neuronal
functioning in affected brain areas and result in the func-
tional deficits characteristic for these diseases [1]. As ageing
is the main risk factor for their development, they represent
a significant medical and socioeconomic problem worldwide.
Despite progress into the understanding of the complex
network of molecular and cellular mechanisms that underlie
the development of these devastating conditions, no effective
pharmacological approaches are yet capable of delaying their
onset and slowing down progression [2].
Compelling data suggest that oxidative stress is one of the
pivotal factors contributing to the common pathophysiology
of neurodegenerative diseases [3, 4]. Oxidative stress occurs
when increased accumulation of reactive oxygen species
(ROS) overwhelms the brain’s intrinsic capacity of oxida-
tive defence, leading to detrimental effects on neuronal
functioning and viability. Due to several reasons, including
the presence of redox active transition metals, the brain is
particularly vulnerable to oxidative injury [5]. Copper is an
essential transition metal required for catalytic activity of
many brain proteins that are involved in various biological
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processes, such as respiration, antioxidant activity, catechol-
amine biosynthesis, and myelin formation [6, 7]. However,
if present in excess, unbound copper ions may initiate redox
cycling reactions, promote production of ROS, and create an
oxidative environment capable of modifying the structure
and function of biological macromolecules, thus threatening
the functionality and viability of brain cells. In the presence
of biological reductants, Cu2+ can be reduced to Cu+ that
via the Fenton-catalysed Haber-Weiss reaction may drive
the generation of extremely toxic hydroxyl radicals, the most
dangerous ROS in biological systems [8].
Dysregulation of copper homeostasis, which results in
altered redox balance and intracellular redox signalling, is
increasingly recognized as an important factor in pathologi-
cal processes underlying neurodegeneration [9, 10]. Despite
some conflicting findings, it seems that serum copper levels
are elevated in patients with Alzheimer’s disease [11, 12].
Besides a copper-induced increase in ROS generation and
the accompanying oxidative stress, aberrant copper/protein
interactions may also contribute to copper toxicity and pro-
gression of the diseases [8, 13]. Thus, in contrast to healthy
conditions, copper binds to amyloid β (Aβ) protein specifi-
cally in Alzheimer’s disease. Cu2+ binding to Aβ increases
its ability to form ubiquitin-containing aggregates and
greatly promotes Aβ-induced generation of ROS [10, 14,
15]. Copper also may compromise the activity of some pro-
teolytic enzymes involved in a degradation of Aβ aggregates.
It can directly interact with metal ions essential for the cata-
lytic and structural properties of metalloproteinases, and can
confer higher proteolytic resistance to aggregated Aβ species
[15]. Furthermore, copper ions promote tau hyperphosphor-
ylation and stimulate its self-aggregation into paired helical
filaments in vitro [16]. Regarding Parkinson’s disease, copper
increases α-synuclein oligomerization, whereas increased
expression of α-synuclein enhances neuronal susceptibility
to copper toxicity [17]. Copper also prevents the ubiquitina-
tion of protein substrates and impairs the proteolytic activity
of the ubiquitin-proteasome system, the main pathway for
the elimination of the misfolded proteins. Moreover, divalent
copper decreases the thermal stability of ubiquitin and
promotes its aggregation into spherical particles, probably
compromising the neuroprotective function of the
ubiquitin-proteasome system [15]. Thus, maintaining copper
homeostasis could be considered as an essential prerequisite
for the preservation of brain health and proper functioning
of neural networks.
Flavonoids represent one of the main groups of bioactive
polyphenolic phytochemicals in human diet and are com-
monly associated with neuroprotection [2, 18]. They can
reduce the risk of developing neurodegenerative pathologies,
rescue neurons from various forms of toxin-induced neuronal
death in vitro, suppress neuroinflammation, improve vascular
function and cerebral blood flow, and enhance cognitive abil-
ities [2, 19]. The molecular mechanisms underlying the bene-
ficial effects of flavonoids on diverse brain pathologies are
primarily attributed to their antioxidant activity (through
direct free radical scavenging, induction of endogenous anti-
oxidative defence, and chelation of metal catalysts) and
modulation of intracellular signalling pathways involved in
neuronal death or survival [2, 18, 20, 21]. In view of their
multiple targets andmechanisms of action, various flavonoids
became increasingly appreciated as promising candidates
for the development of novel and relatively safe therapeu-
tic options in oxidative stress-induced neurodegeneration,
particularly in conditions with deregulated metal homeo-
stasis [18, 22].
Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is one of the
most abundant natural flavonoids and one of the most potent
scavengers of ROS due to its double bonds and hydroxyl
groups that stabilize free radicals [23] (Figure 1). Key struc-
tural features for scavenging activity are the catechol struc-
ture in the B ring, the enol moiety and the 4-keto group in
the C ring, and the 5-OH group in the A ring [24].
Similar to other flavonoids, the neuroprotective effects of
quercetin against oxidative stress-mediated toxicity have
been reported on some types of neuronal cells and assigned
to its antioxidant, antiapoptotic, and signal transduction-
modifying properties [25–28]. The biological effects of quer-
cetin are also influenced by the presence of metal ions as
hydroxy and oxo groups present in the polyphenolic querce-
tin structure may form complexes with various metal ions
[29, 30]. However, although quercetin may inhibit apoptosis
and prevent death in some nontumorigenic cells, it may also
exert direct proapoptotic effects on tumour cells [31, 32].
Furthermore, depending on the dose, it may exert antioxida-
tive as well as prooxidative effects [33]. Chelation of transi-
tion metals is one of the most important mechanisms of the
antioxidative action of quercetin. Through metal chelation,
quercetin may prevent Fenton’s reaction and subsequent
ROS generation. In addition, in a stable chelation complex,
quercetin exhibits a more powerful antioxidative effect as
the scavenging activity of the complex is higher than for
quercetin alone [34]. Formation of the complex depends on
the metal : ligand ratio and the solvent used. Copper and
quercetin may form complexes with copper-to-ligand ratios
of 1 : 1, 2 : 1, 1 : 3, and 1 : 2. The 1 : 1 complex is particularly
prominent in the presence of excess copper [34]. Metal coor-
dination may occur via a carbonyl oxygen in the C ring and
nearby hydroxyl groups (3-OH or 5-OH) in the A or C rings,
and between the ortho-hydroxyl groups in the B ring [34].
The site between the 5-OH group and the 4-oxo group may
be the most important [35]. The estimated binding constant
of the irreversible complexation reaction is K1 = 180 ± 34 ×
103 M−1 at pH7.4 [36]. Following complexation, quercetin
is rapidly autooxidized and forms quinone radicals and/or
quinone intermediates that mediate prooxidative effects.
The other mechanism that contributes to the prooxidative
activity of quercetin is its ability to reduce divalent copper
to Cu(I). Thus, the cytotoxic effects of quercetin may be
explained not only by the increase in ROS production but
also by the production of highly oxidant and electrophilic
oxidation products [29, 36]. A schematic representation of
the antioxidative and prooxidative activities of quercetin is
shown in Figure 1.
In this context, the aim of the present study was to investi-
gate the effects of quercetin against copper-induced toxicity in
P19 neurons to understand better the mechanistic interactions
between, and cellular response to, concomitant treatment with
natural antioxidants and potentially toxic metals. Ultimately,
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this might be useful for the improvement of therapeutic
options in copper-driven neurodegenerative changes.
2. Materials and Methods
2.1. Chemicals. All-trans-retinoic acid (ATRA), cytosine-
arabinofuranoside (AraC), 1,4-diamino-2,3-dicyano-1,4-
bis(2-aminophenylthio)-butadiene (UO126), 2′,7′-dichlor-
ofluorescin diacetate (DCF-DA), 3-(4,5-dimethylthiazol-
2yl)2,5-dyphenyl-2H-tetrazolium bromide (MTT), and
Hoechst 33342 were purchased from Sigma-Aldrich (St.
Louis, MO, USA). All chemicals used for the maintenance
and differentiation of P19 cells, including culture medium
(Dulbecco’Modified Eagle’s Medium, DMEM), foetal bovine
serum (FBS), trypsin, antibiotics, L-glutamine, and an insu-
lin-transferrin-selenium-ethanolamine (ITS-X) supplement
were purchased from Sigma-Aldrich (St. Louis, MO, USA)
or Gibco (Paisley, UK). Wortmannin was purchased from
Ascent Scientific (Princeton, NJ, USA). Copper sulfate penta-
hydrate was obtained from Kemika (Zagreb, Croatia). All
other chemicals used were of analytical grade.
2.2. P19 Cell Culturing and P19 Neuronal Differentiation.
Undifferentiated P19 cells (a pluripotent mouse embryonal
carcinoma cell line) were kindly provided by J. Pachernik
(Prague, Czech Republic). They were cultured in high-
glucose DMEM containing 10% heat-inactivated FBS,
2mM L-glutamine, 100 units/ml penicillin G, and 100μg/ml
streptomycin (growth medium) in a humidified atmosphere
of 5% CO2 at 37
°C. They were passaged every two days.
Neuronal differentiation of P19 cells was induced by
exposure to 1μM all-trans-retinoic acid (ATRA) for 4 days.
Exponentially growing P19 cells (1 × 106) were seeded into
10 cm bacteriological grade Petri dishes containing 10ml of
DMEMmedium supplemented with a reduced concentration
of FBS (5%), 2mM L-glutamine, and antibiotics (induction
medium). ATRA is added immediately after plating. Aggre-
gates (embryonic bodies) of P19 cells were formed after 1-2
days. After 48 h, the old medium was replaced with the fresh
ATRA-containing medium and aggregated cultures were
grown for an additional two days.
After the 4-day ATRA treatment, P19 embryonic bodies
were harvested, washed with phosphate-buffered saline
(PBS), dissociated by trypsinization and pipetting, collected
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Figure 1: (a) Schematic representation of the antioxidative and prooxidative activities of quercetin. Potential Cu(II) chelating sites of
quercetin are shown. Cu complexation may result in antioxidative and prooxidative effects. Antioxidative activity is achieved mainly
through the direct scavenging activity and Cu complexation which prevents copper from participating in a Fenton-type reaction. In
general, the prooxidative activity of quercetin is mainly exhibited in the presence of transition metals such as copper (simplified chemical
reactions of the catechol moiety of quercetin are indicated in (b)). In a reaction of quercetin and Cu2+, a quercetin-semiquinone radical is
formed together with Cu+. The superoxide anion further reacts with quercetin yielding a quercetin-semiquinone radical and hydrogen
peroxide. In a reaction with hydrogen peroxide that is catalysed by Cu2+, quercetin is oxidized to quercetin-semiquinone radicals that
further give quercetin-quinone and quercetin. Hence, these reactions result in redox cycling and further ROS formation. Quercetin also
readily autoxidizes generating a semiquinone radical and a hydroxyl radical. Furthermore, the prooxidative ability of quercetin is related
to its ability to reduce Cu2+. The reduced form (Cu+) induces prooxidative reactions. In the Fenton reaction with hydrogen peroxide, a
hydroxyl radical is formed. Quercetin semiquinones and quinines facilitate the formation of the superoxide anion and reduce GSH levels
further leading to a prooxidative environment.
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by centrifugation (1,250 rpm, 5min), and finally resuspended
in growth medium. For optimal neuronal differentiation,
single cells at a density 105 cells/cm2 were plated onto 96-well
plates or 35mm Petri culture dishes (Sarstedt, Newton, NC,
USA andNunc A/S, Roskilde, Denmark) and grown in growth
mediumfor twodays. Finally, the growthmediumwas changed
to serum-free medium containing DMEM supplemented with
an ITS-X solution containing insulin, transferrin, seleniumand
ethanolamine solution (Gibco), 0.5mML-glutamine, and anti-
biotics (neuron-specific medium) and cells were grown for 2
more days in the presence of 10μM of the mitotic inhibitor
AraC to inhibit proliferation of nonneuronal cells. Complete
neuronal differentiation was confirmed with monoclonal
anti-tubulin β-III mouse IgG, clone TU-20 conjugated with
Alexa Fluor 488 (Millipore, Temecula, CA), see Supplementary
Material, Figure S1. At the end of differentiation procedure,
P19 neurons exert morphological, neurochemical, and
electrophysiological properties resembling neurons from the
mammalian brain, and represent an established model for
pharmacological studies [25, 26, 37].
2.3. Drug Treatment. In all experiments, P19 neurons were
treated for 8 days from the initiation of differentiation
(DIV8). Each batch of cultured cells was divided into control
and drug-treated groups. For inducing oxidative damage,
P19 neurons were incubated with 0.5 or 1mM CuSO4 in
the neuron-specific medium for 24 hours, alone or in the
presence of various concentrations of quercetin. All selected
concentrations of quercetin did not modify the viability of
P19 neurons when applied alone [25, 38]. To examine the
effects of quercetin on the activation of the signalling path-
ways of phosphatidylinositol-3-kinase (PI3K)/Akt and extra-
cellular signal-regulated kinases 1/2 (ERK1/2), P19 neurons
were pretreated with wortmannin and UO126, respectively.
Wortmannin is a nonspecific, covalent inhibitor of PI3K,
an upstream activator of Akt. Wortmannin (30 nM) and
UO126 (10μM) were present 60min prior and during the
exposure to 0.5mM copper and 150μM quercetin. The con-
centrations were chosen based on our preliminary experi-
ments. We selected the smallest concentrations of inhibitors
that modified the neuroprotective effect of quercetin but
did not affect neuronal viability when applied alone.
2.4. Assessment of Neuronal Viability. Survival of P19
neurons was assessed by using colorimetric MTT assay. Cell
viability was estimated according to the ability of P19 neu-
rons to cleave MTT to an insoluble formazan product due
to the activity of mitochondrial dehydrogenases. At the
end of the incubation period, 40μl of MTT solution pre-
pared in neuron-specific medium (final concentration
0.5mg/ml) was added to each well and incubated for 3 h at
37°C. Precipitated formazan was dissolved by adding 160μl
of dimethyl sulfoxide (DMSO). The absorbance of each well
was recorded by an automatic microplate reader at 570nm.
After blank subtraction from all absorbance readings, cell
survival was expressed as the percentage of absorbance of
quercetin- and copper-treated cells relative to that of
untreated control cells.
2.5. Measurement of Intracellular ROS Accumulation. Intra-
cellular production of ROS as a measure of cellular oxidative
stress was detected using the cell permeable substrate DCF-
DA. This fluorogenic probe is widely used for monitoring
cellular oxidative activity. DCF-DA diffuses into the cells
and becomes hydrolysed to nonfluorescent 2′,7′-dichloro-
fluorescin by intracellular esterases. Accumulated 2′,7′
-dichlorofluorescin reacts with intracellular ROS and forms
the highly fluorescent compound dichlorofluorescein
(DCF). The method is reliable and efficient for evaluating
the potency of prooxidants as well as the efficacy of antioxi-
dants against oxidative stress and is suitable as a marker for
the total ROS production [39]. Following treatment, P19
neurons were incubated with 100μM DCF-DA in PBS for
1 h in darkness, rinsed, and incubated for an additional 1 h
in PBS. Oxidation of DCF-DA to DCF was determined using
the Varian Cary Eclipse Fluorescence Spectrophotometer
(Varian Optical Spectroscopy Instruments, Mulgrave, Victo-
ria, Australia) with an excitation wavelength (λex) of 504nm
and an emission wavelength (λem) of 529 nm. The results
were expressed as the percentage of fluorescence intensity
obtained in the control group.
2.6. Determination of Reduced Glutathione (GSH) Levels.
GSH is one of the major nonenzymatic antioxidants pres-
ent in neuronal cells. We monitored changes in GSH levels
with the luminescence-based GSH-Glo Glutathione Assay
(Promega, Madison, WI, USA) according to the manufac-
turer’s instructions. Briefly, the assay couples two chemical
reactions. The first reaction is the conversion of a luciferin
derivative into luciferin, which is catalysed by glutathione-
S-transferase. In the second reaction catalysed by firefly
luciferase, the amount of luciferin produced is detected as
a luminescent signal. The intensity of the signal is propor-
tional to the GSH content. At the end of exposure to
copper and quercetin, the medium was removed and
100μl of the GSH-Glo reagent was added in each well.
The samples were incubated for 30min at RT. Thereafter,
100μl of the luciferin detection reagent was added to each
well, mixed briefly, and incubated for a further 15 minutes.
Emitted light was quantified by the Fluoroskan Ascent FL
luminometer (Thermo Fisher Scientific).
2.7. Determination of Caspase-3/7 Activity. Caspase-3/7
activity was monitored by using the Apo-ONE Homoge-
neous Caspase-3/7 Assay (Promega, Madison, WI, USA).
These two members of the caspase family are the key effector
enzymes in caspase-dependent apoptosis. To perform the
assay, the cell permeabilization buffer and nonfluorescent
caspase substrate Z-DEVD-rhodamine 110 were mixed
(50μl) and added directly to P19 neurons treated with quer-
cetin and copper in 50μl of culture medium. The sample was
shaken for 5min and incubated at RT in the dark for 4 h.
Cleavage of the DEVD peptides by activated caspase-3/7
releases rhodamine 110, which becomes intensely fluorescent
after excitation. The amount of generated fluorescent prod-
uct is proportional to the amount of caspase-3/7 cleavage
activity in each sample. The emitted fluorescence was
recorded on a plate reader (Fluoroskan Ascent FL, Thermo
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Fisher Scientific) at an excitation wavelength of 485 nm and
an emission wavelength of 538 nm.
2.8. Determination of Nuclear Changes by Hoechst Staining.
Hoechst 33342 staining was used to examine nuclear conden-
sation in P19 neurons exposed to copper and quercetin.
Following treatment, attached and floating cells were col-
lected, centrifuged at 250 g, resuspended in 50μl of culture
medium, and stained with 5μM Hoechst 33342 for 10min
at RT. Cells were analyzed under a fluorescent microscope.
Cells with bright blue nuclei were counted. The percentage
of cells with condensed nuclei in relation to the total number
of cells was determined by counting at least 500 neurons.
2.9. Western Blot Analysis of p53, Bax, PUMA, and NME1/2
Protein Expression. The expression of proteins was analyzed
in total cell extracts. Following treatment, P19 neurons
grown in 25 cm2 flasks were washed twice with PBS, lysed
by scrapping into 100μl of RIPA buffer (Sigma-Aldrich, St.
Louis, MO, USA) containing protease inhibitors (cOmplete,
Mini, EDTA-free Protease Inhibitor Cocktail Tablets; Roche,
Indianapolis, IN, USA), and sonicated. The protein concen-
tration was determined using the Pierce BCA Protein Assay
Kit (Thermo Fisher Scientific, Waltham, MA, USA). A
standard curve was developed using a series of bovine serum
albumin dilutions in the 100μg/ml to 1500μg/ml range, and
a linear plot of concentration vs. absorbance (at 570nm) was
generated to determine protein concentration in different
samples. Extracted proteins were resolved using SDS-PAGE
and analyzed by immunoblotting on nitrocellulose mem-
branes (Whatman, GE Healthcare Life Sciences, Berlin,
Germany). Nonspecific binding was blocked by 5% nonfat
milk in Tris-buffered saline containing 0.05% Tween 20
(TBST) for 1 h at RT. Immunoblots were incubated overnight
with a primary antibody and then for 2 h at RT by an appro-
priate secondary antibody. Blots were incubated with the
primary anti-p53 antibody (clone Pab 1801: sc-98 and Pab
240: sc-99, Santa Cruz Biotechnology, 1 : 500; clone Pab
421, kindly provided by Prof. J.-C. Bourdon, Dundee, United
Kingdom, 1 : 200), anti-PUMAα/β antibody (G-3, sc-374223,
Santa Cruz Biotechnology, 1 : 500), anti-Bax antibody (B-9:
sc-7480, Santa Cruz Biotechnology, 1 : 500), and anti-
NME1/NME2 antibody (kindly provided by Drs. I. Lascu,
Bordeaux, France, and S. Volarević, Rijeka, Croatia, 1 : 3000).
The anti-β-actin antibody (AC-15, Sigma-Aldrich, 1 : 5000)
was used for normalization. Immunoreactive bands were
visualized by chemiluminescence detection (Western Light-
ning Plus-ECL, Enhanced Chemiluminescence Substrate,
PerkinElmer, Waltham, MA, USA) of an HRP-labelled
secondary antibody (anti-mouse IgG, GE Healthcare, ECL
mouse IgG, 1 : 5000) and anti-rabbit IgG (Cell Signaling
Technology, 1 : 3000) and quantified by using ImageJ NIH
software after detection with Alliance 4.7 (UVItec Cam-
bridge, London, UK).
2.10. Statistical Analysis. Statistical analyses of the data were
carried out using GraphPad Software (San Diego, CA). All
values are represented as mean ± standard deviation (SD).
Comparisons between group means were evaluated by one-
way ANOVA, and when statistically significant, post hoc
analysis with Dunnett’s multiple comparison test or Tukey’s
test followed. Data on samples fit assumptions for ANOVA
(dependent variable is continuous, observations are indepen-
dent, there are no significant outliers, dependent variable is
approximately normally distributed for each of the indepen-
dent variables, and independent variable combinations pass
Levene’s test for homogeneity of variances). The statistical
significance level was set at α = 0:05.
3. Results
3.1. Effects of Copper and Quercetin on Viability of P19
Neurons.As previously published [40], exposure to increasing
concentrations of copper reduced the viability of P19 neurons.
Treatmentwith 0.5mMCuSO4 for 24h inducedmoderate cell
death (neuronal viability was decreased by 35%), whereas
exposure to 1mM CuSO4 induced more pronounced reduc-
tion of neuronal survival and approximately doubled the
number of dead cells. We investigated the effects of three dif-
ferent concentrations of quercetin (3, 30, and 150μM) on
copper-induced neuronal death. These concentrations of
quercetin did not induce apparent changes in neuronal viabil-
ity when applied alone [38]. As presented in Figure 2(a), in
P19 neurons simultaneously exposed to 0.5mM CuSO4 and
quercetin, the highest concentration of quercetin exerted a
neuroprotective effect and improved neuronal survival,
although neuronal viability was not completely returned to
the control value of the vehicle-treated group (87.5% of the
control group, P < 0:05). Conversely, when quercetin was
applied in the presence of 1mM CuSO4, a decrease in neuro-
nal survival was obtained with 30μM quercetin (neuronal
viability was further decreased by 48% in comparison with
the group exposed solely to 1mM CuSO4), while treatment
with 3 or 150μM quercetin did not modify the effects of
copper (Figure 2(b)).
3.2. The effects of Quercetin against Copper-Induced Neuronal
Death Are Related to ROS Generation. Copper ions upregu-
lated intracellular ROS generation in a dose-dependent
manner (∗P < 0:05 and ∗∗P < 0:0001 vs. control; one-way
ANOVA followed by Dunnett’s test, Figure 3). In mild oxida-
tive conditions induced by exposure to 0.5mM CuSO4, 3 and
30μM quercetin did not affect ROS amounts, while the pres-
ence of 150μM quercetin preserved ROS production at the
physiological levels, indicating an antioxidative mode of
quercetin action at this concentration (Figure 3(a)). In a
highly oxidative environment (Figure 3(b)), 3 and 150μM
concentrations were without effects, whereas 30μM querce-
tin upregulated ROS production (62.8%, P < 0:01), suggest-
ing a prooxidative mechanism of its action. Interestingly, in
severe oxidative stress, 150μM quercetin also tended to
decrease ROS production. It reduced ROS levels by 39.6%
in comparison to copper-treated cells (from 557.9 to 336.9
of relative fluorescence units (RFU)), although this reduction
was not statistically significant. Similarly, a small although
insignificant increase of ROS (18.2%, from 151.9 to
179.6 RFU) was observed for 30μM quercetin in mild oxida-
tive conditions.
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Alterations in ROS production may affect levels of GSH,
themost important endogenousmechanism of nonenzymatic
antioxidative defence. As previously reported, exposure to
divalent copper ions depleted GSH content in neuronal cells
in a dose-dependent manner [40]. In this study, 150μMquer-
cetin induced a further decrease in GSH levels in mild oxida-
tive stress conditions, whereas in P19 neurons treated with
1mM CuSO4, the GSH-reducing effect was observed for 30
and 150μM concentrations (Figure 3(c)).
3.3. Quercetin Prevents Copper-Induced Changes in
Chromatin Condensation and Decreased Caspase-3/7
Activity. ROS may be an initiating factor in triggering
caspase-dependent and caspase-independent neuronal deaths
that are both characterized by nuclear changes in the form of
chromatin condensation [41]. However, the effects of flavo-
noids on cell viability may also result from the inhibition of
the activity of the executioner caspases-3/7 in the classical
apoptotic pathway or may be independent on caspase activity
[25, 42]. To distinguish between these two possibilities, we
monitored caspase-3/7 activity and chromatin density. As
shown in Figure 4(a), in P19 neurons exposed to both
0.5mM and 1mMCuSO4, 150μM quercetin completely pre-
vented a copper-induced increase in caspase-3/7 activation. In
mild oxidative stress, 30μM quercetin did not modify cas-
pase-3/7 activity, while in a highly oxidative environment, this
concentration of quercetin further exacerbated copper-
induced enhancement of caspase-3/7 activation. The intensity
of chromatin condensation was evaluated by staining with the
fluorescent DNA dye Hoechst 33342. In copper-treated P19
neurons, the intensity of DNA staining with Hoechst 33342
was significantly increased. The number of nuclei with con-
densed chromatin was increased by 90% and 189% following
exposure to 0.5mM CuSO4 and 1mM CuSO4, respectively,
and this effect on the increase in chromatin density was more
pronounced than the effect on caspase-3/7 activity. Concom-
itant treatment with 150μM quercetin completely prevented
changes of chromatin morphology in both copper-treated
groups, whereas exposure to 30μM quercetin and 1mM
CuSO4 did not further promote copper-induced changes in
chromatin condensation (Figure 4(b)).
3.4. Quercetin Prevents Copper-Induced Upregulation of
PUMA Expression and Upregulates Expression of NME1
Protein. To elucidate the molecular mechanisms of the neu-
roprotective action of quercetin further, we monitored
changes in the expression of proteins involved in the regula-
tion of neuronal death cascade and whose expression is
typically modified in oxidative conditions. As quercetin at 3
and 30μM concentrations did not modify neuronal survival
and ROS formation, we assessed changes induced only by
150μM quercetin. Transcription factor p53 plays an impor-
tant role in determining neuronal death or survival by coor-
dinating transcription of pro- and antioxidative proteins and
through the regulation of mitochondrial metabolism and
ROS production [43]. However, by using three different
p53 antibodies, we found no copper- or quercetin-induced
changes in p53 levels. The same result was obtained for
Bax, a downstream target of p53. However, expression of
PUMA, an important regulator of neuronal apoptosis, was
highly upregulated by 0.5mM CuSO4. This increase in
PUMA expression was reduced in P19 neurons concomi-
tantly treated with quercetin. We also monitored changes in
the expression of nucleoside diphosphate kinase NME1. In
response to environmental stimuli, this enzyme can translo-
cate to the nucleus and regulate transcription and DNA
repair [44]. Although expression of NME1 protein was not
significantly altered in P19 neurons treated with 0.5mM
CuSO4 alone, NME1 gene expression was enhanced by 69%
in the presence of 150μM quercetin (Figure 5).
3.5. The Neuroprotective Effect of Quercetin Is Mediated
through the Modulation of Akt and ERK1/2 Signalling
Pathways. To investigate whether neuroprotective effects
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Figure 2: Effects of quercetin on the survival of P19 neurons in the presence of excess copper. For the analysis of neuronal survival, P19
neurons (30 × 103/well) were exposed to the indicated concentrations of CuSO4 and quercetin in a 96-well plate for 24 h, and for 3 h with
MTT afterwards. Precipitated formazan crystals were dissolved with DMSO, and the absorbance was recorded at 570 nm. In moderately
injured neurons exposed to 0.5mM CuSO4, 150μM quercetin improved neuronal survival (a). Treatment with 1mM CuSO4 induced
more severe neuronal death. The presence of 30 μM quercetin further exacerbated the cytotoxic effects of copper, whereas a
150μM concentration was without effect (b). Data represent the mean ± SD from four independent experiments performed in
quadruplets. ∗P < 0:0001 vs. cont (0 group); aP < 0:05 and bP < 0:01 vs. the copper-treated group (one-way ANOVA followed by
Tukey’s test: (a) Fð4,39Þ = 101:1, P < 0:0001 ; (b) Fð4,31Þ = 15:04, P < 0:0001).
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were mediated through the modulation of intracellular
signalling, we treated P19 neurons concomitantly with cop-
per, quercetin, and inhibitors of the Akt and ERK signalling
pathways. Wortmannin is a specific, covalent inhibitor of
PI3K. Akt/PKB is located downstream of PI3K and, there-
fore, functions as part of a wortmannin-sensitive signalling
pathway. UO126 is a highly selective inhibitor of mitogen-
activated protein kinase kinase MEK1/2 that further activates
ERK1/2 by phosphorylation at Thr and Tyr residues [45].
Our results indicate that the neuroprotective effect of querce-
tin was mediated through the activation of Akt and ERK1/2
signalling as the prosurvival effect of quercetin was no longer
visible in the presence of wortmannin (Figure 6(a)) and
UO126 (Figure 6(b)).
4. Discussion
Deregulation of metal homeostasis, accompanied by
enhanced production of free radicals and increased oxidative
stress, is directly involved in the onset and progression of
neurodegenerative diseases (for reviews, see [13, 46]). Natu-
ral antioxidants have potential to reestablish redox homeo-
stasis and reduce or prevent metal-induced oxidative
damage [47–49]. Besides their ability to act as antioxidants,
metal chelators, and modulators of intracellular signalling,
flavonoids may inhibit the formation of Aβ fibrils [50, 51]
and improve the activity of the ubiquitin-proteasome system
[52, 53]. Hence, flavonoids, including quercetin, represent a
promising multitarget drug option, particularly if applied
during the early stage of neurodegenerative processes.
Accordingly, a few dietary intervention studies have demon-
strated an ability of phytochemicals to improve neurological
dysfunction [54]. We studied the effects of quercetin, one of
the most abundant flavonoids from human diet, against
copper-initiated neuronal death. Previous studies indicated
that Cu2+-induced oxidative injury can be attenuated by
polyphenols [6, 55]. Our results suggest that the effects of
copper and quercetin on neuronal survival could be governed
by their concentrations and are dependent on the severity of
toxic insult. In mild oxidative stress, quercetin may exert a
desirable neuroprotective action and improve neuronal
survival. However, in severely damaged neurons, quercetin,
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Figure 3: Effects of quercetin on ROS production and GSH levels in copper-mediated oxidative stress conditions. ROS levels were quantified
by measuring fluorescence intensity after incubation with 2′,7′-dichlorofluorescin diacetate (DCF-DA). In P19 neurons exposed to 0.5mM
CuSO4, only the highest concentration of quercetin prevented a copper-induced increase in ROS production (a). In severely damaged
neurons, 30 μM quercetin exacerbated a prooxidative effect of copper (b). 30 and 150μM quercetin exacerbated a copper-induced decrease
in GSH content (c). Data represent the mean ± SD from four independent experiments performed in quadruplets. aP < 0:05 and bP < 0:01
vs. the copper-treated group; ∗P < 0:05, ∗∗P < 0:0001 vs. control (one-way ANOVA followed by post hoc Dunnett’s test).
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applied at specific dose, is capable of exacerbating the toxic
effect of copper leading to more pronounced neuronal death.
The dual effects of quercetin on cell viability were also
observed in other studies [33, 56].
The toxic effects of copper are mostly attributed to its role
in oxidative stress induction and downstream death events
[27, 57]. Hence, the prevention of ROS production might
be a promising strategy against copper-induced toxicity and
neurodegeneration in general [58]. We previously demon-
strated that quercetin applied alone attenuated the genera-
tion of radical species in P19 neurons [38]. However,
monitoring ROS production in the presence of copper ions
revealed the antioxidative as well as prooxidative effects of
the polyphenolic structure of quercetin, in a manner related
to its effects on neuronal viability. In copper-induced mild
oxidative stress, the neuroprotection offered by quercetin
was associated with its antioxidative properties, while its pro-
oxidative ability largely contributed to increasing neuronal
death in severe oxidative stress. In P19 neurons exposed to
low and high concentrations of hydrogen peroxide, quercetin
exhibited only an antioxidative action [25], pointing out to
the contribution of copper ions in its prooxidative action.
Additional studies also demonstrated that the effects of
quercetin in the presence of copper ions are dose-
dependent and related to the intensity of oxidative processes
[59–61]. They also pointed out that the mechanisms of quer-
cetin/copper interactions are rather complex and worth
studying further. It has been shown that quercetin induces
oxidative DNA damage at specific sites in the presence of
Cu(II); however, with high doses of quercetin, DNA damage
is decreased [59]. In another study, quercetin at low Cu2+
concentrations protected from DNA damage, whereas quer-
cetin at higher Cu2+ concentrations promoted DNA cleavage
[60]. By measuring the extent of lipid peroxidation on low-
density lipoprotein preparations, Filipe et al. [61] reported
that quercetin at high Cu2+ concentrations decreased lipid
peroxidation. In the presence of low Cu2+ concentrations,
quercetin exhibited a dual effect acting as a prooxidant at
low concentration and exerting antioxidant activity when
applied at high concentrations. Flavonoids exert their antiox-
idative action via various mechanisms including direct ROS
trapping, prevention of peroxidation, inhibition of ROS-
producing enzymes, and chelation of transition metals [34].
Regarding the chelation process, interactions between quer-
cetin and copper(II) are promoted in the presence of excess
copper, and the copper-quercetin complex is a better free
radical acceptor than quercetin alone [30, 34]. However, in
the presence of metal ions, natural antioxidants may switch
their biological effects to prooxidant activity. Several studies
investigating the interactions between quercetin and copper
ions in different conditions in vitro demonstrated the proox-
idative nature of their interplay. For example, quercetin
undergoes a slow autooxidation under physiological pH, pro-
ducing hydrogen peroxide. In the presence of copper, it is
more prone to autooxidation, and accordingly generates
more hydrogen peroxide [36]. In the presence of Cu2+,
phenolic compounds such as quercetin are oxidized to a
semiquinone radical. The semioxidized quercetin is not
stable and undergoes a second oxidation reaction that yields
ortho-quinone and superoxide anion (O2
•). The superoxide
anion reacts with catalytic Cu+ and forms hydrogen peroxide
that is further converted into a hydroxyl radical (•OH)
promoting formation of more ROS [62]. However, even the
prooxidant activity of quercetin may stimulate a cellular
defence response by activating redox-dependent signal trans-
duction pathways leading to the upregulation of antioxida-
tive enzymes [63]. As suggested by Filipe et al. [61], it is
likely that prooxidative and antioxidative mechanisms are
operative simultaneously, but at certain combinations of
copper and quercetin concentrations, one of the mecha-
nisms prevails, determining the overall effect on neuronal
viability.
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Figure 4: Effects of quercetin on caspase-3/7 activity and nuclear condensation. In moderately injured P19 neurons, a protective
concentration of quercetin abolished copper-induced caspase-3/7 activation (a) and nuclear condensation (b), while in severely injured
neurons, a prooxidative concentration of quercetin increased caspase activation without affecting chromatin condensation. Results of
caspase-3/7 activity are expressed as mean ± SD from 4 independent experiments performed in duplicates. Changes in nuclear
condensation were determined from 3 independent experiments. At least 500 nuclei per group were examined in each experiment, in
randomly selected fields. aP < 0:05, cP < 0:001, and dP < 0:0001 vs. the copper-treated group; ∗P < 0:01 and ∗∗P < 0:0001 vs. control (one-
way ANOVA followed by post hoc Dunnett’s test).
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The main oxidized metabolite of quercetin, quercetin-
quinone, exerts specific reactivity towards thiol groups which
may lead to the loss of protein functions and jeopardize neu-
ronal functioning [64]. At first, quercetin preferentially reacts
with GSH; however, at depleted GSH levels, it reacts with
protein thiols, forming relatively stable adducts [64]. In our
study, the overall effect on GSH content was not consistent
with neuronal survival. Quercetin applied at a concentration
of 150μM exacerbated the copper-induced decrease of the
GSH content in both mild and severe oxidative stress. GSH
levels were similar in neurons exposed to 1mM CuSO4 alone
(viability of 35% in comparison to the control group) and in
neurons exposed to 0.5mM CuSO4 and 150μM quercetin
(viability of 88% in comparison to the control group). This
indicates that downstream effects of ROS on neuronal death
pathways and signalling cascades, rather than protein dys-
functions due to the formation of thiol adducts, determine
the overall impact on neuronal viability.
Upregulation of ROS levels is usually accompanied with
the activation of executioner caspases-3/7, particularly in a
mildly oxidative environment [65]. In severe oxidative injury
characterized by a prominent decrease in neuronal viability,
neuronal cells also die by necrosis [25]. Our study shows that
copper induces caspase-3/7 activation in a dose-dependent
manner. Treatment with 0.5mMCuSO4 induced a very small
(27%), statistically significant increase, whereas effects of
1mM CuSO4 were more than doubled. Structural changes
of chromatin are much more pronounced than the effect on
caspase-3/7 activity with exposure to CuSO4. As condensed
nuclei are a hallmark of both caspase-dependent and
caspase-independent cell death, we suggest that in mild
oxidative stress, neuronal cells predominantly died by a
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Figure 5: Signalling by apoptotic and oxidative stress-related pathways. The effects of copper and quercetin on the expression of p53, Bax,
PUMAα/β, and NME1/NME2 in moderate oxidative stress were monitored for 24 h from the beginning of treatment with 0.5mM CuSO4
and 150μM quercetin, and proteins of total cell extracts were separated on 10 or 11% SDS polyacrylamide gel electrophoresis and
transferred to a nitrocellulose membrane. Blots were probed with primary antibodies, followed by the appropriate horseradish peroxidase-
labelled secondary antibody. Immunoreactivity was detected using enhanced chemiluminescence. β-Actin was used as loading control for
normalization. Data are expressed as mean ± SD from up to five immunoblots of three independently prepared cell lysates. Exposure to
copper and quercetin did not affect p53 and Bax expression. However, quercetin diminished copper-induced upregulation of PUMA and
stimulated NME1 expression. Following densitometric analysis, obtained data were analyzed with one-way ANOVA followed by
Dunnett’s test (aP < 0:05, cP < 0:001). Representative Western blots are also presented.
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caspase-independent mechanism, but that in a highly oxida-
tive environment, the classic apoptotic machinery is triggered,
together with necrotic death, as the number of dead cells
exceeded the number of dead cells with chromatin changes
[40]. Nevertheless, effects of quercetin on copper-induced
enzymatic and nuclear changes were in a good correlation
with the overall effect of quercetin on neuronal viability.
Transcription factor p53 may play an important role in
determining cell death or survival by guiding cellular
response to diverse genotoxic challenges, including oxidative
stress, primarily by regulating transcription of various pro-
and antiapoptotic genes [43]. Bax is another common
effector of cell death. In response to various stress stimuli, it
translocates to the mitochondria and induces membrane per-
meabilization, enabling the release of various proapoptotic
effectors [66]. However, in our conditions, the levels of p53
and Bax remained stable. Previous studies have shown that
Bax translocation, rather than its upregulation, could be the
crucial event for initiating neuronal death after exposure to
various agents that increase production of ROS [67]. As for
Bax, it is possible that p53 translocation, instead of p53
upregulation, is the most important factor for the initiation
of death events at this concentration of copper [68, 69]. How-
ever, quercetin also did not modify expression of either p53
or Bax indicating that these proteins did not contribute to
the prosurvival effect of quercetin.
PUMA is a potent inducer of p53-independent death. It is
able to activate Bax [70] and antagonize the function of anti-
apoptotic members of the Bcl-2 family [71]. Under basal con-
ditions, PUMA is expressed in very small amounts, but is
rapidly induced by various forms of stressors, including
altered redox status. Its expression could be regulated by
various transcription factors that respond to toxic stimuli
[71]. The PUMA gene promoter contains binding sites for
several transcription factors in addition to p53 (such as
p73, c-Myc, FoxO3A, CHOP, E2F1, and AP-1), which could
be differentially activated in different forms of cellular stress
[72]. This probably may explain our results showing prom-
inent copper-induced upregulation of PUMA together with
unchanged p53 levels. Cotreatment with quercetin partially
prevented PUMA induction, indicating that the suppres-
sion of PUMA activation could be the underlying mecha-
nism of the observed neuroprotective action of quercetin
in P19 neurons.
The role of NME1 in oxidative stress response has been
recently emerging. This enzyme is mostly known for its
nucleoside diphosphate kinase activity, although it also may
exert many functions within the cell nucleus as well. Recent
data indicate that DNA-damaging agents induce the pres-
ence of NME1 in the nucleus where it may regulate gene
transcription acting as a transcription factor, or it may partic-
ipate in the repair of DNA strand breaks [44]. Furthermore,
NME1 overexpression promoted the survival of primary rat
cortical neurons during excitotoxicity, hydrogen peroxide-
induced oxidative stress, and oxygen-glucose deprivation
[73]. NME1 was also secreted extracellularly in an in vitro
model of traumatic brain injury which also might indicate
its neuroprotective and regenerative function [74]. In line
with these findings, NME1 expression was upregulated in
quercetin-treated P19 neurons, suggesting its important role
in promoting neuronal survival in copper-induced oxidative
stress. Of note, it has been shown that NME1 may modulate
Akt and ERK signalling pathways [75].
Growing evidence indicates that flavonoids exert neuro-
protective effects by modulating various signalling cascades
[18, 19]. We have previously shown that quercetin promotes
the survival of P19 neurons in hydrogen peroxide-induced
oxidative stress by modulating Akt and ERK1/2 signalling
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Figure 6: Effects of wortmannin and UO126 against the neuroprotective action of quercetin in moderately injured P19 neurons. P19 neurons
were treated with 30 nM wortmannin and 10μM UO126 for 1 h prior to and during the treatment with 0.5mM CuSO4. At 24 h from the
beginning of treatment with copper and quercetin, the survival of P19 neurons was determined by MTT assay. Exposure to both
wortmannin (a) and UO126 (b) prevented the beneficial effects of quercetin on neuronal survival in copper-induced oxidative stress
conditions. Values are expressed as means ± SD from five independent experiments performed in quadruplets. aP < 0:05 and bP < 0:01 vs.
the copper- or the copper- and quercetin-treated group (one-way ANOVA followed by post hoc Tukey’s test).
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[26]. Similarly, pharmacological inhibition of PI3K/Akt and
ERK1/2 pathways prevents the beneficial effects of quercetin
on copper-induced neuronal death. Signal transduction
through the PI3K/Akt and ERK1/2 pathways contributes to
many aspects of neuronal functioning, and both pathways
are considered as potential therapeutic targets in neurode-
generation [76, 77]. It has been shown that quercetin may
induce the expression of the brain-derived neurotrophic
factor (BDNF) which in turn activates the ERK and PI3K
pathways [78]. Potential targets, as well as underlying mech-
anisms, that possibly determine the net survival of P19
neurons following exposure to quercetin and copper, are
represented in Figure 7.
5. Conclusions
We observed a neuroprotective effect at a particular con-
centration of quercetin in modest oxidative stress condi-
tions induced by exposure to divalent copper ions. In
addition to antioxidative activities, this effect is mediated
through the Akt and ERK signalling cascades. Quercetin
reduces the increase in PUMA expression and upregulates
NME1, which ultimately prevents the stimulation of cas-
pase-3/7 activity and chromatin condensation. As such,
quercetin and other flavonoids acting as modulators of
Akt and ERK signalling pathways represent promising ther-
apeutic approaches to alleviate the consequences of mild
copper-induced oxidative stress.
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11Oxidative Medicine and Cellular Longevity
Basic, Clinical and Translational Neuroscience CoRE-
NEURO (“Experimental and clinical research of hypoxic-
ischemic damage in perinatal and adult brain”; GA
KK01.1.1.01.0007 funded by the European Union through
the European Regional Development Fund), and in part by
NIH grant AG005138.
Supplementary Materials
Figure S1: differentiation of P19 neuronal cells. Immunofluo-
rescence staining against β-III tubulin demonstrates com-
plete neuronal differentiation. (Supplementary Materials)
References
[1] L. Gan, M. R. Cookson, L. Petrucelli, and A. R. la Spada, “Con-
verging pathways in neurodegeneration, from genetics to
mechanisms,” Nature Neuroscience, vol. 21, no. 10, pp. 1300–
1309, 2018.
[2] I. Figueira, R. Menezes, D. Macedo, I. Costa, and C. N. dos
Santos, “Polyphenols beyond barriers: a glimpse into the
brain,” Current Neuropharmacology, vol. 15, no. 4, pp. 562–
594, 2017.
[3] G. H. Kim, J. E. Kim, S. J. Rhie, and S. Yoon, “The role of oxi-
dative stress in neurodegenerative diseases,” Experimental
Neurobiology, vol. 24, no. 4, pp. 325–340, 2015.
[4] Z. Liu, T. Zhou, A. C. Ziegler, P. Dimitrion, and L. Zuo, “Oxi-
dative stress in neurodegenerative diseases: from molecular
mechanisms to clinical applications,” Oxidative Medicine and
Cellular Longevity, vol. 2017, Article ID 2525967, 11 pages,
2017.
[5] J. N. Cobley, M. L. Fiorello, and D. M. Bailey, “13 reasons why
the brain is susceptible to oxidative stress,” Redox Biology,
vol. 15, pp. 490–503, 2018.
[6] L. M. Gaetke and C. K. Chow, “Copper toxicity, oxidative
stress, and antioxidant nutrients,” Toxicology, vol. 189, no. 1-
2, pp. 147–163, 2003.
[7] C. M. Ackerman and C. J. Chang, “Copper signaling in the
brain and beyond,” The Journal of Biological Chemistry,
vol. 293, no. 13, pp. 4628–4635, 2018.
[8] L. M. Gaetke, H. S. Chow-Johnson, and C. K. Chow, “Copper:
toxicological relevance and mechanisms,” Archives of Toxicol-
ogy, vol. 88, no. 11, pp. 1929–1938, 2014.
[9] C. Garza-Lombó, Y. Posadas, L. Quintanar, M. E. Gonsebatt,
and R. Franco, “Neurotoxicity linked to dysfunctional metal
ion homeostasis and xenobiotic metal exposure: redox signal-
ing and oxidative stress,” Antioxidants & Redox Signaling,
vol. 28, no. 18, pp. 1669–1703, 2018.
[10] F. Cioffi, R. H. I. Adam, and K. Broersen, “Molecular mecha-
nisms and genetics of oxidative stress in Alzheimer’s disease,”
Journal of Alzheimer’s Disease, vol. 72, no. 4, pp. 981–1017,
2019.
[11] R. Squitti, D. Lupoi, P. Pasqualetti et al., “Elevation of serum
copper levels in Alzheimer’s disease,” Neurology, vol. 59,
no. 8, pp. 1153–1161, 2002.
[12] M. Ventriglia, S. Bucossi, V. Panetta, and R. Squitti, “Copper in
Alzheimer’s disease: a meta-analysis of serum, plasma, and
cerebrospinal fluid studies,” Journal of Alzheimer's Disease,
vol. 30, no. 4, pp. 981–984, 2012.
[13] S. Rivera-Mancía, I. Pérez-Neri, C. Ríos, L. Tristán-López,
L. Rivera-Espinosa, and S. Montes, “The transition metals cop-
per and iron in neurodegenerative diseases,” Chemico-Biologi-
cal Interactions, vol. 186, no. 2, pp. 184–199, 2010.
[14] P. Faller, “Copper and zinc binding to amyloid-beta: coordina-
tion, dynamics, aggregation, reactivity and metal-ion transfer,”
Chembiochem, vol. 10, no. 18, pp. 2837–2845, 2009.
[15] G. Grasso, A. M. Santoro, V. Lanza et al., “The double faced
role of copper in Aβ homeostasis: a survey on the interrela-
tionship between metal dyshomeostasis, UPS functioning
and autophagy in neurodegeneration,” Coordination Chemis-
try Reviews, vol. 347, pp. 1–22, 2017.
[16] A. Kim, S. Lim, and Y. Kim, “Metal ion effects on Aβ and tau
aggregation,” International Journal of Molecular Sciences,
vol. 19, no. 1, p. 128, 2018.
[17] X. Wang, D. Moualla, J. A. Wright, and D. R. Brown, “Copper
binding regulates intracellular alpha-synuclein localisation,
aggregation and toxicity,” Journal of Neurochemistry,
vol. 113, no. 3, pp. 704–714, 2010.
[18] N. A. Kelsey, H. M. Wilkins, and D. A. Linseman, “Nutraceu-
tical antioxidants as novel neuroprotective agents,” Molecules,
vol. 15, no. 11, pp. 7792–7814, 2010.
[19] D. Vauzour, K. Vafeiadou, A. Rodriguez-Mateos, C. Rendeiro,
and J. P. E. Spencer, “The neuroprotective potential of flavo-
noids: a multiplicity of effects,” Genes & Nutrition, vol. 3,
no. 3-4, pp. 115–126, 2008.
[20] S. Kumar and A. K. Pandey, “Chemistry and biological activi-
ties of flavonoids: an overview,” The Scientific World Journal,
vol. 2013, 16 pages, 2013.
[21] M. Říha, J. Karlíčková, T. Filipský et al., “In vitro evaluation of
copper-chelating properties of flavonoids,” RSC Advances,
vol. 4, no. 62, pp. 32628–32638, 2014.
[22] P. Maher, “The potential of flavonoids for the treatment of
neurodegenerative diseases,” International Journal of Molecu-
lar Sciences, vol. 20, no. 12, p. 3056, 2019.
[23] A. W. Boots, G. R. Haenen, and A. Bast, “Health effects of
quercetin: from antioxidant to nutraceutical,” European Jour-
nal of Pharmacology, vol. 585, no. 2-3, pp. 325–337, 2008.
[24] A. Amić, B. Lučić, V. Stepanić et al., “Free radical scavenging
potency of quercetin catecholic colonic metabolites: thermo-
dynamics of 2H+/2e- processes,” Food Chemistry, vol. 218,
pp. 144–151, 2017.
[25] M. Jazvinšćak Jembrek, L. Vuković, J. Puhović, J. Erhardt, and
N. Oršolić, “Neuroprotective effect of quercetin against hydro-
gen peroxide-induced oxidative injury in P19 neurons,” Jour-
nal of Molecular Neuroscience, vol. 47, no. 2, pp. 286–299,
2012.
[26] M. Jazvinšćak Jembrek, J. Vlainić, V. Čadež, and S. Šegota,
“Atomic force microscopy reveals new biophysical markers
for monitoring subcellular changes in oxidative injury: neuro-
protective effects of quercetin at the nanoscale,” PLoS One,
vol. 13, no. 10, p. e0200119, 2018.
[27] H. L. Tseng, C. J. Li, L. H. Huang et al., “Quercetin 3-O-methyl
ether protects FL83B cells from copper induced oxidative
stress through the PI3K/Akt and MAPK/Erk pathway,” Toxi-
cology and Applied Pharmacology, vol. 264, no. 1, pp. 104–
113, 2012.
[28] L. G. Costa, J. M. Garrick, P. J. Roquè, and C. Pellacani,
“Mechanisms of neuroprotection by quercetin: counteract-
ing oxidative stress and more,” Oxidative Medicine and Cel-
lular Longevity, vol. 2016, 10 pages, 2016.
[29] V. Radovanović, J. Vlainić, N. Hanžić et al., “Neurotoxic effect
of ethanolic extract of propolis in the presence of copper ions is
12 Oxidative Medicine and Cellular Longevity
mediated through enhanced production of ROS and stimula-
tion of caspase-3/7 activity,” Toxins, vol. 11, no. 5, p. 273, 2019.
[30] S. B. Bukhari, S. Memon, M. Mahroof-Tahir, and M. I. Bhan-
ger, “Synthesis, characterization and antioxidant activity
copper-quercetin complex,” Spectroscopy, vol. 71, no. 5,
pp. 1901–1906, 2009.
[31] C. Park, H. S. So, C. H. Shin et al., “Quercetin protects the
hydrogen peroxide-induced apoptosis via inhibition of mito-
chondrial dysfunction in H9c2 cardiomyoblast cells,” Bio-
chemical Pharmacology, vol. 66, no. 7, pp. 1287–1295, 2003.
[32] A. Rauf, M. Imran, I. A. Khan et al., “Anticancer potential of
quercetin: a comprehensive review,” Phytotherapy Research,
vol. 32, no. 11, pp. 2109–2130, 2018.
[33] A. Robaszkiewicz, A. Balcerczyk, and G. Bartosz, “Antioxida-
tive and prooxidative effects of quercetin on A549 cells,” Cell
Biology International, vol. 31, no. 10, pp. 1245–1250, 2007.
[34] A. Pȩkal, M. Biesaga, and K. Pyrzynska, “Interaction of querce-
tin with copper ions: complexation, oxidation and reactivity
towards radicals,” Biometals, vol. 24, no. 1, pp. 41–49, 2011.
[35] L. Mira, M. T. Fernandez, M. Santos, R. Rocha, M. H.
Florêncio, and K. R. Jennings, “Interactions of flavonoids
with iron and copper ions: a mechanism for their antioxi-
dant activity,” Free Radical Research, vol. 36, no. 11,
pp. 1199–1208, 2009.
[36] H. El Hajji, E. Nkhili, V. Tomao, and O. Dangles, “Interactions
of quercetin with iron and copper ions: complexation and
autoxidation,” Free Radical Research, vol. 40, no. 3, pp. 303–
320, 2009.
[37] A. C. Grobin, J. R. Inglefield, R. D. Schwartz-Bloom, L. L.
Devaud, and A. L. Morrow, “Fluorescence imaging of GABAA
receptor-mediated intracellular [Cl−] in P19-N cells reveals
unique pharmacological properties,” Brain Research, vol. 827,
no. 1-2, pp. 1–11, 1999.
[38] M. Jazvinšćak Jembrek, A. Čipak Gašparović, L. Vuković,
J. Vlainić, N. Žarković, and N. Oršolić, “Quercetin supplemen-
tation: insight into the potentially harmful outcomes of neuro-
degenerative prevention,” Naunyn-Schmiedeberg's Archives of
Pharmacology, vol. 385, no. 12, pp. 1185–1197, 2012.
[39] H. Wang and J. A. Joseph, “Quantifying cellular oxidative
stress by dichlorofluorescein assay using microplate reader,”
Free Radical Biology & Medicine, vol. 27, no. 5-6, pp. 612–
616, 1999.
[40] M. Jazvinšćak Jembrek, J. Vlainić, V. Radovanović, J. Erhardt,
and N. Oršolić, “Effects of copper overload in P19 neurons:
impairment of glutathione redox homeostasis and crosstalk
between caspase and calpain protease systems in ROS-
induced apoptosis,” Biometals, vol. 27, no. 6, pp. 1303–1322,
2014.
[41] S. Elmore, “Apoptosis: a review of programmed cell death,”
Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2016.
[42] J. B. White, J. Beckford, S. Yadegarynia, N. Ngo, T. Lialiutska,
and M. d’Alarcao, “Some natural flavonoids are competitive
inhibitors of caspase-1, -3, and -7 despite their cellular toxic-
ity,” Food Chemistry, vol. 131, no. 4, pp. 1453–1459, 2012.
[43] D. B. Wang, C. Kinoshita, Y. Kinoshita, and R. S. Morrison,
“p53 and mitochondrial function in neurons,” Biochimica et
Biophysica Acta (BBA) - Molecular Basis of Disease,
vol. 1842, no. 8, pp. 1186–1197, 2014.
[44] G. S. Puts, M. K. Leonard, N. V. Pamidimukkala, D. E. Snyder,
and D. M. Kaetzel, “Nuclear functions of NME proteins,” Lab-
oratory Investigation, vol. 98, no. 2, pp. 211–218, 2018.
[45] J. Bain, L. Plater, M. Elliott et al., “The selectivity of protein
kinase inhibitors: a further update,” The Biochemical Journal,
vol. 408, no. 3, pp. 297–315, 2007.
[46] K. A. Jellinger, “Recent advances in our understanding of neu-
rodegeneration,” Journal of Neural Transmission, vol. 116,
no. 9, pp. 1111–1162, 2009.
[47] K. Jomova and M. Valko, “Advances in metal-induced oxida-
tive stress and human disease,” Toxicology, vol. 283, no. 2-3,
pp. 65–87, 2011.
[48] A. Singh, R. Kukreti, L. Saso, and S. Kukreti, “Oxidative stress:
a key modulator in neurodegenerative diseases,” Molecules,
vol. 24, no. 8, p. 1583, 2019.
[49] M. Simunkova, S. H. Alwasel, I. M. Alhazza et al., “Manage-
ment of oxidative stress and other pathologies in Alzheimer’s
disease,” Archives of Toxicology, vol. 93, no. 9, pp. 2491–
2513, 2019.
[50] T. Akaishi, T. Morimoto, M. Shibao et al., “Structural require-
ments for the flavonoid fisetin in inhibiting fibril formation of
amyloid beta protein,” Neuroscience Letters, vol. 444, no. 3,
pp. 280–285, 2008.
[51] F. Yin, J. Liu, X. Ji, Y. Wang, J. Zidichouski, and J. Zhang, “Sili-
binin: a novel inhibitor of Aβ aggregation,” Neurochemistry
International, vol. 58, no. 3, pp. 399–403, 2011.
[52] S. Mandel and M. B. Youdim, “Catechin polyphenols: neuro-
degeneration and neuroprotection in neurodegenerative
diseases,” Free Radical Biology & Medicine, vol. 37, no. 3,
pp. 304–317, 2004.
[53] J. Chakraborty, U. Rajamma, N. Jana, and K. P. Mohanakumar,
“Quercetin improves the activity of the ubiquitin-proteasomal
system in 150Q mutated huntingtin-expressing cells but exerts
detrimental effects on neuronal survivability,” Journal of Neuro-
science Research, vol. 93, no. 10, pp. 1581–1591, 2015.
[54] M. Ayaz, A. Sadiq, M. Junaid et al., “Flavonoids as prospective
neuroprotectants and their therapeutic propensity in aging
associated neurological disorders,” Frontiers in Aging Neuro-
science, vol. 11, 2019.
[55] N. R. Perron, C. R. García, J. R. Pinzón, M. N. Chaur, and J. L.
Brumaghim, “Antioxidant and prooxidant effects of polyphe-
nol compounds on copper-mediated DNA damage,” Journal
of Inorganic Biochemistry, vol. 105, no. 5, pp. 745–753, 2011.
[56] G. H. Heeba and M. E. Mahmoud, “Dual effects of quercetin in
doxorubicin-induced nephrotoxicity in rats and its modula-
tion of the cytotoxic activity of doxorubicin on human carci-
noma cells,” Environmental Toxicology, vol. 31, no. 5,
pp. 624–636, 2014.
[57] A. R. White, G. Multhaup, F. Maher et al., “The Alzheimer’s
disease amyloid precursor protein modulates copper-induced
toxicity and oxidative stress in primary neuronal cultures,”
The Journal of Neuroscience, vol. 19, no. 21, pp. 9170–9179,
1999.
[58] R. Giampietro, F. Spinelli, M. Contino, and N. A. Colabufo,
“The pivotal role of copper in neurodegeneration: a new strat-
egy for the therapy of neurodegenerative disorders,”Molecular
Pharmaceutics, vol. 15, no. 3, pp. 808–820, 2018.
[59] N. Yamashita, H. Tanemura, and S. Kawanishi, “Mechanism
of oxidative DNA damage induced by quercetin in the pres-
ence of Cu(II),” Mutation Research, vol. 425, no. 1, pp. 107–
115, 1999.
[60] T. Jun, Z. Liancai, andW. Bochu, “Effects of quercetin on DNA
damage induced by copper ion,” International Journal of Phar-
macology, vol. 3, no. 1, pp. 19–26, 2007.
13Oxidative Medicine and Cellular Longevity
[61] P. Filipe, J. Haigle, J. N. Silva et al., “Anti- and pro-oxidant
effects of quercetin in copper-induced low density lipoprotein
oxidation: quercetin as an effective antioxidant against pro-
oxidant effects of urate,” European Journal of Biochemistry,
vol. 271, no. 10, pp. 1991–1999, 2004.
[62] Y. Iwasaki, T. Hirasawa, Y. Maruyama et al., “Effect of interac-
tion between phenolic compounds and copper ion on antioxi-
dant and pro-oxidant activities,” Toxicology in Vitro, vol. 25,
no. 7, pp. 1320–1327, 2011.
[63] J. Terao, K. Murota, and Y. Kawai, “Conjugated quercetin
glucuronides as bioactive metabolites and precursors of
aglycone in vivo,” Food & Function, vol. 2, no. 1, pp. 11–
17, 2011.
[64] A. W. Boots, H. Li, R. P. F. Schins et al., “The quercetin para-
dox,” Toxicology and Applied Pharmacology, vol. 222, no. 1,
pp. 89–96, 2007.
[65] T. F. Beckhauser, J. Francis-Oliveira, and R. De Pasquale,
“Reactive oxygen species: physiological and physiopathologi-
cal effects on synaptic plasticity,” Journal of Experimental Neu-
roscience, vol. 10s1, pp. JEN.S39887–JEN.S39848, 2016.
[66] M. Fricker, A. M. Tolkovsky, V. Borutaite, M. Coleman, and
G. C. Brown, “Neuronal cell death,” Physiological Reviews,
vol. 98, no. 2, pp. 813–880, 2018.
[67] D. Steckley, M. Karajgikar, L. B. Dale et al., “Puma is a domi-
nant regulator of oxidative stress induced Bax activation and
neuronal apoptosis,” The Journal of Neuroscience, vol. 27,
no. 47, pp. 12989–12999, 2007.
[68] L. P. Zhao, C. Ji, P. H. Lu, C. Li, B. Xu, and H. Gao, “Oxygen
glucose deprivation (OGD)/re-oxygenation-induced in vitro
neuronal cell death involves mitochondrial cyclophilin-
D/P53 signaling axis,” Neurochemical Research, vol. 38, no. 4,
pp. 705–713, 2013.
[69] A. V. Vaseva, N. D. Marchenko, K. Ji, S. E. Tsirka,
S. Holzmann, and U. M. Moll, “p53 opens the mitochondrial
permeability transition pore to trigger necrosis,” Cell,
vol. 149, no. 7, pp. 1536–1548, 2012.
[70] L. Vela, O. Gonzalo, J. Naval, and I. Marzo, “Direct interaction
of bax and bak proteins with Bcl-2 homology domain 3 (BH3)-
only proteins in living cells revealed by fluorescence comple-
mentation,” The Journal of Biological Chemistry, vol. 288,
no. 7, pp. 4935–4946, 2013.
[71] J. Yu and L. Zhang, “PUMA, a potent killer with or without
p53,” Oncogene, vol. 27, no. S1, pp. S71–S83, 2008.
[72] P. Hikisz and Z. M. Kiliańska, “Puma, a critical mediator of cell
death—one decade on from its discovery,” Cellular & Molecu-
lar Biology Letters, vol. 17, no. 4, pp. 646–669, 2012.
[73] J. Teoh, S. Boulos, J. Chieng, N. W. Knuckey, and B. P. Meloni,
“Erythropoietin increases neuronal NDPKA expression, and
NDPKA up-regulation as well as exogenous application pro-
tects cortical neurons from in vitro ischemia-related insults,”
Cellular and Molecular Neurobiology, vol. 34, no. 3, pp. 379–
392, 2014.
[74] P. Romani, M. Ignesti, G. Gargiulo, T. Hsu, and V. Cavaliere,
“Extracellular NME proteins: a player or a bystander?,” Labo-
ratory Investigation, vol. 98, no. 2, pp. 248–257, 2018.
[75] M. Q. Li, J. Shao, Y. H. Meng et al., “NME1 suppression pro-
motes growth, adhesion and implantation of endometrial stro-
mal cells via Akt and MAPK/Erk1/2 signal pathways in the
endometriotic milieu,” Human Reproduction, vol. 28, no. 10,
pp. 2822–2831, 2013.
[76] S. Subramaniam and K. Unsicker, “ERK and cell death:
ERK1/2 in neuronal death,” The FEBS Journal, vol. 277,
no. 1, pp. 22–29, 2010.
[77] K. Sánchez-Alegría, M. Flores-León, E. Avila-Muñoz,
N. Rodríguez-Corona, and C. Arias, “PI3K signaling in neu-
rons: a central node for the control of multiple functions,”
International Journal of Molecular Sciences, vol. 19, no. 12,
p. 3725, 2018.
[78] T. Numakawa, H. Odaka, and N. Adachi, “Actions of brain-
derived neurotrophin factor in the neurogenesis and neuronal
function, and its involvement in the pathophysiology of brain
diseases,” International Journal of Molecular Sciences, vol. 19,
no. 11, p. 3650, 2018.
14 Oxidative Medicine and Cellular Longevity
